Simple, cost-effective test may be used to help improve early diagnosis of Mild Cognitive Impairment (MCI) and provide interventions as early as possible
An international team of scientists have developed a new way to screen for age-related cognitive decline at home using a test which asks people to detect sounds and flashes on their laptop or phone.
Developed by researchers from Switzerland and the UK, the study shows that the simple, cost-effective test may be used to help improve early diagnosis of Mild Cognitive Impairment (MCI) and provide interventions as early as possible. This is particularly relevant given that MCI can develop into Alzheimer’s disease in 30 to 50 percent of people.
The research, which included UK researchers Dr Trudi Edginton from City, University of London and Dr Alison Eardley from the University of Westminster, also sheds new light on our understanding of how the brains of older individuals process information from the different senses. It is published today in today in Nature Scientific Reports.
There are currently no diagnostic blood tests like those for diabetes for MCI, and instead the existing diagnosis involves lengthy neuropsychological assessments with tests of cognitive control and memory, along with questions about daily activities and mood. These costly tests require training, often take a lot of patient and clinician time, and can be impacted by factors such as the individual’s IQ, socio-economic status and even the testers themselves. As a result, with an ageing global population, and an around 50 million people estimated to be living with dementia worldwide, there is an urgent need for such a test.
As part of the study, the 123 participants were simply asked to press a button whenever they saw a flash of light or heard a sound. At times, the flashes or sounds were presented alone, but at other times the two appeared simultaneously. The participants included 51 healthy young adults, 49 healthy older adults and 23 older MCI adults.
The researchers, who were led by Professor Micah Murray from the University of Lausanne, Switzerland, then extracted two measures about each person’s performance: 1) whether they were faster at detecting flashes or sound, and 2) the extent to which they benefited from detecting an auditory-visual event versus either flashes or sounds. Dr Paul Matusz from the University of Lausanne explained that by using just these two measures, the team could accurately tell if a person was diagnosed with MCI using standard clinical tests.
Professor Murray, Professor of Radiology and Clinical Neurosciences at the University Hospital Centre and University of Lausanne, said:
“We are particularly excited about this work because it shows how very simple tests can help clinical practice by reaching a wider population, at a lower cost. We are happy that our findings clarify the link between our vision and hearing and their role in supporting memory (dys-)function; it becomes increasingly clear that how preserved our cognitive skills are as we age depends on how intact our senses are. This importantly extends our similar existing findings in school-age children.”
Dr Alison Eardley, a psychologist at the University of Westminster (London, UK), explained the impetus for the study:
“The current tools used for assessing abnormal ageing are by no means unanimously supported or even sufficient on their own. Not a single existing assessment instrument currently provides an unequivocal diagnosis. The choice of the primary diagnostic tool itself continues to be a topic of a heated debate.”
Dr Trudi Edginton, a cognitive neuroscientist and clinical psychologist at City, University of London (London, UK), said:
“Our findings open the exciting possibility that a simple perceptual task could be a valuable complementary screening and assessment tool for MCI. However, the test we introduced should not yet be considered as a substitute or replacement for tests currently used in clinical practice.
The team is now designing new ways to validate this new screening tool and exploring the role of neurotransmitter systems in age-related and pathological changes in sensory and cognitive functions to inform early diagnosis and potential treatment options.”
The Latest on: Mild Cognitive Impairment
via Google News
The Latest on: Mild Cognitive Impairment
- Concussion and long-term cognitive impairment among professional or elite sport-persons: a systematic reviewon February 27, 2020 at 10:07 am
Outcome–long-term cognitive function as assessed by neurocognitive tests or clinical evidence of mild cognitive impairment or Alzheimer disease or dementia assessed as clinical diagnosis (including ...
- Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairmenton February 27, 2020 at 2:29 am
... psychological stress with cognitive outcomes in a multi-centre longitudinal study of people with amnestic mild cognitive impairment (aMCI) we assessed three parameters of psychological stress ...
- Can PET Match Up Areas of Protein Deposit With Alzheimer’s Symptoms?on February 26, 2020 at 6:13 pm
Cécile Tissot and Pedro Rosa-Neto of McGill University in Verdun, Canada, compared AZD4694 amyloid PET and MK-6240 tau PET to the global score on the neuropsychiatric inventory questionnaire (NPI-Q) ...
- Task Force Questions Value of Routine Screening for Cognitive Impairmenton February 26, 2020 at 11:21 am
The report is actually an update of a similar one issued by the USPSTF in 2014. Although it’s unclear how many clinicians take these types of recommendations on board, the report could change how ...
- USPSTF: Evidence Lacking for Cognitive Impairment Screeningon February 25, 2020 at 8:06 pm
Overall, 224 randomized clinical trials and three observational studies assessed treatment of mild cognitive impairment or mild-to-moderate dementia; none of the treatment trials were linked with a ...
- A path to early diagnosis of mild cognitive impairment and dementia: validity and reliability of the myMemCheck® self-administered screening tool.on February 25, 2020 at 8:06 pm
Barriers to the early detection of mild cognitive impairment (MCI) and dementia can delay diagnosis and treatment. myMemCheck® was developed as a rapid free cognitive self-assessment tool that can be ...
- USPSTF: Insufficient evidence to evaluate benefits, harms of screening for cognitive impairmenton February 25, 2020 at 1:35 pm
The U.S. Preventive Services Task Force wrote in JAMA that there is insufficient evidence to assess the benefits and harms of screening for cognitive impairment — its collective term for dementia and ...
- U.S. medical panel thinks twice about pushing cognitive screening for dementiaon February 25, 2020 at 9:31 am
Once other causes are ruled out, neuropsychological tests can help establish a diagnosis. "If I detect mild cognitive impairment, the first thing I'll do is tell a patient I don't have any drugs for ...
- Medical experts decline to endorse cognitive screening for older adultson February 25, 2020 at 9:21 am
Once other causes are ruled out, neuropsychological tests can help establish a diagnosis. “If I detect mild cognitive impairment, the first thing I’ll do is tell a patient I don’t have any drugs for ...
via Bing News